# CYclosporine A in Shockable Out-of-hospital Cardiac Arrest ResUScitation

> **NCT02887807** · PHASE3 · WITHDRAWN · sponsor: **Hospices Civils de Lyon**

## Conditions studied

- Shockable Out of Hospital Cardiac Arrest

## Interventions

- **DRUG:** Single intravenous bolus of cyclosporine A (2.5 mg/kg) at the onset of resuscitation
- **DRUG:** Single intravenous bolus of placebo at the onset of resuscitation

## Key facts

- **NCT ID:** NCT02887807
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02887807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02887807, "CYclosporine A in Shockable Out-of-hospital Cardiac Arrest ResUScitation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02887807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
